Vir Biotechnology's total assets for Q1 2025 were $1.31B, a decrease of -6.51% from the previous quarter. VIR total liabilities were $263.91M for the fiscal quarter, a 6.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.